Related Experiment Videos
Treatment strategy for cutaneous malignant melanoma
Arata Tsutsumida1, Hiroshi Furukawa, Yuhei Yamamoto
1Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Hokkaido University, Kita 15, Sapporo 060-8638, Japan. tsutsu@med.hokudai.ac.jp
International Journal of Clinical Oncology
|October 26, 2005
Summary
Cutaneous malignant melanoma diagnoses are increasing in Japan, with early detection improving cure rates. Advances in treatment offer hope for patients with advanced or recurrent melanoma.
Area of Science:
- Oncology
- Dermatology
Background:
- Rising incidence of cutaneous malignant melanoma in Japan.
- Increased early-stage diagnoses due to improved awareness and diagnostic tools.
- Advanced or recurrent melanoma presents a significant prognostic challenge.
Purpose of the Study:
- To review the clinical evidence for current treatment recommendations.
- To cover primary and recurrent cutaneous melanoma management in Japan.
Main Methods:
- Review of clinical evidence.
- Analysis of treatment recommendations.
Main Results:
- Early melanoma diagnosis correlates with high cure rates.
- Thicker lesions or nodal involvement indicate a worse prognosis.
- Recent therapeutic advancements are noted.
Conclusions:
- Current treatment guidelines for cutaneous melanoma in Japan are based on reviewed clinical evidence.
- Management strategies address both primary and recurrent cases.